Benefits of Stereotactic Radiosurgery for Brain Tumor Patients

There are more than 120 types of brain tumors, according to the American Brain Tumor Association.

New Jersey CyberKnife treats brain tumors and metastatic brain lesions with stereotactic radiosurgery (SRS). Treatment is delivered by CyberKnife® technology, providing an important alternative for patients who are not candidates for surgery or seek a noninvasive treatment option.

Unlike surgery for brain tumors, which can last over three hours, requires general anesthesia and a hospital stay, CyberKnife treats patients without incision or sedation, allowing patients to return to their normal activities following treatment.

CyberKnife treats brain tumor patients in five or fewer treatments, a much shorter time period than conventional forms of radiation therapy for brain tumors, which usually require consecutive treatments five days per week for up to 6 weeks.

CyberKnife produces a highly conformal radiation beam, which ‘matches’ the shape of the tumor, minimizing radiation exposure to surrounding healthy brain tissue.

Unlike some radiosurgery systems, CyberKnife does not use an invasive head frame for the treatment of brain tumors, eliminating the need for local anesthesia. It can be particularly beneficial for patients with tumors near critical structures in the brain.

To learn more about the benefits of CyberKnife treatment for brain tumors, click here.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.